CTOs on the Move

Millenium Laboratories

www.millenniumlabs.com

 
Millennium Laboratories, a leader in the science of toxicology and pharmacogenetics, is transforming the way health care providers improve clinical outcomes. Millennium helps practitioners provide personalized care to patients in need through its patient-centered research and education initiatives and its ability to respond to evolving health care challenges with advanced technologies.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Sound Technology Inc

Sound Technology Inc is a State College, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LSS Data Systems

LSS Data Systems is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Kyruus Health

As the industry`s largest care access platform Kyruus Health enables our partners to efficiently guide and match people to the care that`s right for them. We create connections across the entire healthcare ecosystem so that every stakeholder can access and harness the most accurate, comprehensive, and contextually relevant information. By enabling informed decisions and confident action, we support healthier outcomes, reduce friction in healthcare, and grant more time back in everyone`s day. At the heart of care access, we connect people to healthcare in a whole new way.

Elmore Medical Center Foundation Inc

Elmore Medical Center Foundation Inc is a Mountain Home, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III